In this episode of Denatured, sponsored by SK Pharmteco, Jennifer Smith-Parker speaks to Arvind Singh, vice president and global head of supply chain. In this episode, we discuss how CDMOs are revamping supply‑chain strategy for a new generation of intricate modalities. Topics addressed include moving from smarter raw‑material sourcing and precision cold‑chain logistics to navigating geopolitical and regulatory uncertainty and deploying AI to building sustainable, scalable capabilities from clinical through commercial.This episode is presented in partnership with SK Pharmteco. HostJennifer Smith-Parker, Director of Insights, BioSpaceGuestArvind Singh, VP & Global Head of Supply ChainDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from BioSpace
When vision fades: Rethinking wet AMD and the durability gap
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
Breaking borders: Building biotech scale in Benelux
Get summaries like this every morning.
Free AI-powered recaps of BioSpace and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.